| Primary |
| Prophylaxis |
75.9% |
| Lung Disorder |
7.8% |
| Ventricular Assist Device Insertion |
5.0% |
| Bronchopulmonary Dysplasia |
2.8% |
| Respiratory Distress |
2.1% |
| Neonatal Respiratory Distress Syndrome Prophylaxis |
1.4% |
| Persistent Foetal Circulation |
1.4% |
| Pulmonary Hypertension |
1.4% |
| Cardiogenic Shock |
0.7% |
| Cerebral Malaria |
0.7% |
| Respiratory Failure |
0.7% |
|
| Patent Ductus Arteriosus |
24.5% |
| Pulmonary Haemorrhage |
11.2% |
| Staphylococcal Sepsis |
8.2% |
| Intraventricular Haemorrhage Neonatal |
7.1% |
| Sepsis Neonatal |
6.1% |
| Neonatal Disorder |
4.1% |
| Neonatal Hypotension |
4.1% |
| Pulmonary Oedema |
4.1% |
| Thrombocytopenia |
4.1% |
| Patent Ductus Arteriosus Repair |
3.1% |
| Retinopathy Of Prematurity |
3.1% |
| Sepsis |
3.1% |
| Therapy Non-responder |
3.1% |
| Central Venous Pressure Increased |
2.0% |
| Necrotising Enterocolitis Neonatal |
2.0% |
| Oxygen Saturation Decreased |
2.0% |
| Periventricular Leukomalacia |
2.0% |
| Post Procedural Haemorrhage |
2.0% |
| Pulmonary Hypertension |
2.0% |
| Respiratory Disorder Neonatal |
2.0% |
|
| Secondary |
| Pulmonary Hypertension |
30.1% |
| Mean Arterial Pressure |
17.5% |
| Maintenance Of Anaesthesia |
8.7% |
| Induction Of Anaesthesia |
7.7% |
| Prophylaxis |
5.5% |
| Nonketotic Hyperglycinaemia |
4.4% |
| Drug Use For Unknown Indication |
3.8% |
| Ill-defined Disorder |
3.3% |
| Premedication |
3.3% |
| Drug Exposure During Pregnancy |
2.2% |
| Thrombosis |
2.2% |
| Ventricular Dysfunction |
2.2% |
| Ventricular Failure |
2.2% |
| Sedation |
1.6% |
| Anticoagulant Therapy |
1.1% |
| Attention Deficit/hyperactivity Disorder |
1.1% |
| Blood Pressure Decreased |
1.1% |
| Neonatal Respiratory Distress Syndrome |
1.1% |
| Cardiac Arrest |
0.5% |
| Hypotonia |
0.5% |
|
| Death |
14.0% |
| Patent Ductus Arteriosus |
14.0% |
| Pulmonary Oedema |
14.0% |
| Tricuspid Valve Incompetence |
14.0% |
| Drug Exposure During Pregnancy |
4.7% |
| Pulseless Electrical Activity |
4.7% |
| Swelling Face |
4.7% |
| Bradycardia |
2.3% |
| Cardiac Arrest |
2.3% |
| Cardio-respiratory Arrest |
2.3% |
| Cerebral Haemorrhage |
2.3% |
| Hypoxia |
2.3% |
| Premature Baby |
2.3% |
| Pulmonary Veno-occlusive Disease |
2.3% |
| Respiratory Arrest |
2.3% |
| Right Ventricular Failure |
2.3% |
| Staphylococcal Bacteraemia |
2.3% |
| Staphylococcal Sepsis |
2.3% |
| Stevens-johnson Syndrome |
2.3% |
| Ventricular Fibrillation |
2.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
28.7% |
| Pulmonary Hypertension |
14.9% |
| Pulmonary Arterial Hypertension |
10.8% |
| Product Used For Unknown Indication |
6.9% |
| Cardiac Failure |
5.0% |
| Mechanical Ventilation |
3.3% |
| Anaesthesia |
3.0% |
| Hypotension |
3.0% |
| Maintenance Of Anaesthesia |
2.5% |
| Sedation |
2.5% |
| Tracheobronchitis |
2.5% |
| Coronary Artery Bypass |
2.2% |
| Induction Of Anaesthesia |
2.2% |
| Procedural Pain |
2.2% |
| Hypertension |
1.9% |
| Cardiac Aneurysm Repair |
1.7% |
| Catheterisation Cardiac |
1.7% |
| Fusarium Infection |
1.7% |
| Induction And Maintenance Of Anaesthesia |
1.7% |
| Premedication |
1.7% |
|
| Deafness Neurosensory |
12.7% |
| Platelet Count Decreased |
11.4% |
| Respiratory Failure |
10.1% |
| Hypotension |
6.3% |
| Right Ventricular Failure |
6.3% |
| Thrombosis |
6.3% |
| Pneumothorax |
5.1% |
| Pulmonary Hypertension |
5.1% |
| Renal Failure Acute |
5.1% |
| Fear |
3.8% |
| Sepsis |
3.8% |
| White Blood Cell Count Increased |
3.8% |
| Abdominal Sepsis |
2.5% |
| Death |
2.5% |
| Haemoptysis |
2.5% |
| Intraventricular Haemorrhage Neonatal |
2.5% |
| Livedo Reticularis |
2.5% |
| Off Label Use |
2.5% |
| Pain |
2.5% |
| Persistent Foetal Circulation |
2.5% |
|
